Live feed
·
INSIDERFilingvia Quantisnow
Amedisys Inc logo

Amedisys (AMED) director Coye received 1,678 shares

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Molly Joel Coye (director at Amedisys Inc, AMED) reported that they received 1,678 shares on May 3, 2024. After these transactions the filing shows 7,128 shares held directly.

Reporting person
Coye Molly Joel
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
May 3, 2024Grant or award (A)Common Stock1+1,678--7,128 direct

Holdings before and after

  • Common Stock: 5,450 to 7,128 direct

Footnotes from the filing

  1. 1. The Issuer awarded the Reporting Person 1,678 time-based Restricted Stock Units, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest 100% on May 3, 2025, predicated upon the Reporting Person's continued service as a non-employee member of the Issuer's Board of Directors through the vesting date.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Coye report in this AMED Form 4?

Molly Joel Coye (director at Amedisys Inc, AMED) reported that they received 1,678 shares on May 3, 2024. After these transactions the filing shows 7,128 shares held directly.

How many AMED shares does Coye hold after this filing?

The filing shows 7,128 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for AMED

Earlier insider filings at AMED

Quantisnow market dataNASDAQ
Amedisys Inc logo
AMED
Amedisys Inc
Market cap
30-day
Sector
Health Care
Industry
Medical/Nursing Services
Get push alerts for AMED

Follow AMED and get a push notification the moment its next story breaks.

Full AMED profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMED (Amedisys Inc) and more on Quantisnow.